Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
International Cancer Conference Journal|January 8, 2024
S-1 as an alternative treatment after 5-fluorouracil-induced coronary vasospasm in a patient with small bowel adenocarcinoma: a case reportNoriko Mitome, Nozomu Machida, Yoriko Shichiri, et al.
Japanese Journal of Clinical Oncology|May 2, 2024
A randomized phase III trial of postoperative surveillance for pathological stage II and IIIA non-small cell lung cancer (JCOG2012, PHOENIX)Kenta Tane, Satoshi Shiono, Masashi Wakabayashi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 27, 2026
Sustainable platform for cross-disease evaluation: Integrated JCOG trials database (JCOG2509A)Ryosuke Kita, Noriko Mitome, Junki Mizusawa, et al.
JTCVS Open|July 1, 2026
Artificial intelligence-based algorithm for predicting outcomes in early-stage lung cancer: An annotation-free imaging artificial intelligence studyKeiju Aokage, Jumpei Ukita, Mamoru Miura, et al.
Japanese Journal of Clinical Oncology|June 27, 2025
A multi-institutional randomized phase III trial of lobectomy versus segmentectomy for radiologically solid-predominant non-small cell lung cancer with a ground-glass opacity and tumor diameter > 2 cm and ≤ 3 cm: JCOG2217 (STRONG)Noriko Mitome, Aritoshi Hattori, Kenji Suzuki, et al.
Clinical Lung Cancer|May 10, 2026
A Multi-Institutional Randomized Phase III Trial of Neoadjuvant Chemoimmunotherapy Followed By Surgery Versus Upfront Surgery in Patients With Resectable Clinical Stage II-III Non-Small Cell Lung Cancer: JCOG2317 (NATCH-ICI)Noriko Mitome, Akira Hamada, Masashi Wakabayashi, et al.
Japanese Journal of Clinical Oncology|June 18, 2026
A multicenter randomized phase II/III trial of salvage treatment for refractory primary central nervous system lymphoma using tirabrutinib: JCOG2314 (ReSTART)Kota Kawabata, Fumiharu Ohka, Ryuta Saito, et al.
Japanese Journal of Clinical Oncology|October 24, 2024
Protocol summary of a randomized phase III study: comparing systemic therapy with and without debulking surgery (primary tumour resection) for clinical stage IVA (cT1-2bN0-1M1a) non-small cell lung cancer with radiologically undetermined pleural dissemination JCOG2103 (DEBULK-LUNG)Yuta Sekino, Tomoyuki Hishida, Hiroshige Yoshioka, et al.
International Journal of Clinical Oncology|January 22, 2026
Clinical complete response and predictive factors in HER2-positive early breast cancer treated with neoadjuvant chemotherapy aimed at omission of surgery: an exploratory analysis of the JCOG1806 trialHideo Shigematsu, Tomomi Fujisawa, Fumikata Hara, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 9, 2025
Gut Microbiota in Advanced NSCLC Receiving Chemoimmunotherapy: An Ancillary Biomarker Study From the Phase III Trial JCOG2007 (NIPPON)Taiki Hakozaki, Kentaro Tanaka, Yoshimasa Shiraishi, et al.
Pageof 2